|
Volumn 80, Issue 4, 2012, Pages 546-553
|
The XIENCE nano everolimus eluting coronary stent system for the treatment of small coronary arteries: the SPIRIT Small Vessel trial.
a b b b b b b b b b
b
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CARDIOVASCULAR AGENT;
DRUG DERIVATIVE;
EVEROLIMUS;
RAPAMYCIN;
AGED;
ANGIOCARDIOGRAPHY;
ARTICLE;
CLINICAL TRIAL;
CORONARY ARTERY DISEASE;
CORONARY ARTERY THROMBOSIS;
DRUG ELUTING STENT;
FEMALE;
HEART INFARCTION;
HUMAN;
INSTRUMENTATION;
KAPLAN MEIER METHOD;
MALE;
MIDDLE AGED;
MORTALITY;
MULTICENTER STUDY;
NANOMEDICINE;
PROSPECTIVE STUDY;
PROSTHESIS;
RADIOGRAPHY;
RESTENOSIS;
TIME;
TRANSLUMINAL CORONARY ANGIOPLASTY;
TREATMENT OUTCOME;
UNITED STATES;
AGED;
ANGIOPLASTY, BALLOON, CORONARY;
CARDIOVASCULAR AGENTS;
CORONARY ANGIOGRAPHY;
CORONARY ARTERY DISEASE;
CORONARY RESTENOSIS;
CORONARY THROMBOSIS;
DRUG-ELUTING STENTS;
FEMALE;
HUMANS;
KAPLAN-MEIER ESTIMATE;
MALE;
MIDDLE AGED;
MYOCARDIAL INFARCTION;
NANOMEDICINE;
PROSPECTIVE STUDIES;
PROSTHESIS DESIGN;
SIROLIMUS;
TIME FACTORS;
TREATMENT OUTCOME;
UNITED STATES;
|
EID: 84855573223
PISSN: None
EISSN: 1522726X
Source Type: Journal
DOI: 10.1002/ccd.23397 Document Type: Article |
Times cited : (48)
|
References (0)
|